Practice of Dapagliflozin Application in Patients with Type 2 Diabetes Mellitus
Journal Title: Міжнародний ендокринологічний журнал - Year 2015, Vol 5, Issue 69
Abstract
The article presents the results of using new antihyperglycemic drug — a selective inhibitor of the sodium-glucose cotransporter type 2 — dapagliflozin in patients with type 2 diabetes mellitus. The influence of this drug on the effectiveness of glycemic control, blood pressure level, lipid profile, body weight has been analyzed, compliance has been assessed. According to the practice of dapagliflozin application in the combination antidiabetic therapy, the drug is easy to use, provides sufficient glycemic control (significant decrease in glycated hemoglobin by an average of 0.98 %), reduces body weight in the presence of obesity or overweight (a decrease in the body mass index by an average of 1.78 kg/m2), has a positive effect on blood pressure, has no significant effect on the correction of dyslipidemia in the presence of transient adverse reactions in some women in the form of cystitis and vulvovaginitis, does not require discontinuation of treatment. Application of dapagliflozin in combination hypoglycemic therapy in patients with diabetes type 2 is suitable for achieving compensation.
Authors and Affiliations
L. V. Shkala, Ya. I. Kleban, O. V. Cherpak, O. A. Karapetian, T. H. Volkovska
Keywords
Related Articles
- EP ID EP219670
- DOI -
- Views 55
- Downloads 0
Vaspin is a compensatory molecule in the pathogenesis of metabolic obesity-induced disorders
Background. The development of disabling effects in obesity is connected to the functioning disorders of adipose tissue hormones — the adipokines, including vaspin. The nature of changes in vaspin content in Ukrainians w...
Clinical and pathogenetic importance of hormonal natriuretic peptides in gout
Background. In addition to purine metabolism disorders, systems of pro-inflammatory cytokines, matrix metalloproteinases and eicosanoids, various medium molecular weight compounds can participate in the pathogenesis of g...
Siofor Efficacy in Treatment of Patients with Obesity and Hyperinsulinism on the Prediabetes Stage
The efficacy of Siofor for patients with constitutional and diet-induced obesity and hyperinsulinism has been analyzed. This medication in effective dose was found to have positive effect on lipid and carbohydrate metabo...
Frederick Banting and Insulin Discovery (75th Anniversary of Tragic Death)
The article has been written in order to commemorate Canadian scientist Frederick Banting, the discoverer of insulin. There are briefly enlightened biography of the scientist and a history of insulin discovery. There is...
Analysis of negative results of the treatment for diabetic foot syndrome in outpatients
Background. Festering inflammation of lower extremities is one of the most frequent surgical complications of diabetes mellitus (DM). The results of its treatment can not be admitted as satisfactory. The aim of the study...